[Updated 12/29/16, 2:50 pm. See below.] The FDA has rejected a Cempra antibiotic drug for community-acquired bacterial pneumonia citing the same safety issues that came to light when an independent advisory panel to the regulator evaluated the drug in... Read more »
You’ve probably seen the Internet memes. “When 2016 started, I looked like this. [Insert picture of young Leo DiCaprio.] Now I look like this. [Leo, with mountain beard, after mud-wrestling with a grizzly in The Revenant.]” In life science terms,... Read more »
We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here, with looks at key studies in... Read more »
[Updated, 4:28 pm ET, see below] After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical data—usually from big, late-stage studies—that can sometimes make or break... Read more »
When farmers want crops that have a better shot at resisting disease or taking up nutrients, they use breeding techniques to develop new varieties. Crossing plants to create these varieties is an agricultural practice that dates back thousands of years.
Breeding... Read more »
’Tis the season for giving gifts. And increasingly, those shiny new toys and gadgets can be connected to the Internet—from TVs to watches, speakers to Barbie dolls.
That Internet connection opens up a ton of possibilities for how we can... Read more »
Biogen didn’t go far to find its new CEO. The company promoted chief commercial officer Michel Vounatsos to the top spot on Monday, succeeding former chief executive George Scangos.
When Scangos announced this summer that he would step down from Biogen... Read more »
The 21st Century Cures Act is now law. New York wants to play in the biotech big leagues. The FDA under Trump will have license to approve drugs faster and could have a former top official back on board as commissioner.... Read more »
If you’re not much of a podcast listener and you have a sense that you’re missing out on a lot of great content, you’re absolutely right. But now is a good time to fix that, thanks to a new profusion of... Read more »